| The CD153 vaccine is a senotherapeutic option for preventing the accumulation of senescent T cells in mice S Yoshida, H Nakagami, H Hayashi, Y Ikeda, J Sun, A Tenma, H Tomioka, ... Nature communications 11 (1), 2482, 2020 | 108 | 2020 |
| Development of vaccine for dyslipidemia targeted to a proprotein convertase subtilisin/kexin type 9 (PCSK9) epitope in mice R Kawakami, Y Nozato, H Nakagami, Y Ikeda, M Shimamura, S Yoshida, ... PloS one 13 (2), e0191895, 2018 | 60 | 2018 |
| SARS-CoV-2-induced humoral immunity through B cell epitope analysis in COVID-19 infected individuals S Yoshida, C Ono, H Hayashi, S Fukumoto, S Shiraishi, K Tomono, ... Scientific Reports 11 (1), 5934, 2021 | 28 | 2021 |
| Glial fibrillary acidic protein (GFAP) is a novel biomarker for the prediction of autoimmune diabetes Z Pang, A Kushiyama, J Sun, T Kikuchi, H Yamazaki, Y Iwamoto, ... The FASEB Journal 31 (9), 4053-4063, 2017 | 27 | 2017 |
| Prevention of bleomycin-induced pulmonary fibrosis by a RANKL peptide in mice N Ju, H Hayashi, M Shimamura, S Baba, S Yoshida, R Morishita, ... Scientific Reports 12 (1), 12474, 2022 | 22 | 2022 |
| Preclinical study of a DNA vaccine targeting SARS-CoV-2 H Hayashi, J Sun, Y Yanagida, T Otera, R Kubota-Koketsu, T Shioda, ... Current research in translational medicine 70 (4), 103348, 2022 | 18 | 2022 |
| Development of a novel RANKL-based peptide, microglial healing peptide1-AcN (MHP1-AcN), for treatment of ischemic stroke M Shimamura, H Nakagami, H Shimizu, H Mukai, R Watanabe, ... Scientific reports 8 (1), 17770, 2018 | 15 | 2018 |
| Preventative effects of the partial RANKL peptide MHP1-AcN in a mouse model of imiquimod-induced psoriasis N Ju, M Shimamura, H Hayashi, Y Ikeda, S Yoshida, A Nakamura, ... Scientific Reports 9 (1), 15434, 2019 | 14 | 2019 |
| Phase I study to assess the safety and immunogenicity of an intradermal COVID-19 DNA vaccine administered using a pyro-drive jet injector in healthy adults H Nakagami, H Hayashi, J Sun, Y Yanagida, T Otera, F Nakagami, ... Vaccines 10 (9), 1427, 2022 | 13 | 2022 |
| Therapeutic Effects of Systemic Administration of the Novel RANKL‐Modified Peptide, MHP1, for Ischemic Stroke in Mice M Shimamura, H Nakagami, H Shimizu, K Wakayama, T Kawano, Y Ikeda, ... BioMed Research International 2018 (1), 4637084, 2018 | 11 | 2018 |
| Modified DNA vaccine confers improved humoral immune response and effective virus protection against SARS-CoV-2 delta variant H Hayashi, J Sun, Y Yanagida, T Otera, M Sasai, CY Chang, JA Tai, ... Scientific reports 12 (1), 20923, 2022 | 10 | 2022 |
| Prevention of acute lung injury by a novel CD14-inhibitory receptor activator of the NF-κB ligand peptide in mice N Ju, H Hayashi, M Shimamura, S Yoshida, R Nakamaru, H Nakagami, ... Immunohorizons 5 (6), 438-447, 2021 | 7 | 2021 |
| Development of an IL-17A DNA vaccine to treat systemic lupus erythematosus in mice H Koriyama, Y Ikeda, H Nakagami, M Shimamura, S Yoshida, H Rakugi, ... Vaccines 8 (1), 83, 2020 | 7 | 2020 |
| Development of anti-thrombotic vaccine against human S100A9 in rhesus monkey M Shimamura, K Kaikita, H Nakagami, T Kawano, N Ju, H Hayashi, ... Scientific Reports 11 (1), 11472, 2021 | 6 | 2021 |
| Evaluating the potential of the GFAP‐KLH immune‐tolerizing vaccine for type 1 diabetes in mice Z Pang, M Higuchi, H Koriyama, S Yoshida, H Kurinami, M Shimamura, ... FEBS letters 591 (1), 129-136, 2017 | 6 | 2017 |
| Prevention of vascular dementia via immunotherapeutic blockade of renin-angiotensin system in a rat model K Wakayama, M Shimamura, S Yoshida, H Hayashi, N Ju, H Nakagami, ... Brain Research 1772, 147667, 2021 | 4 | 2021 |
| Intradermal administration of DNA vaccine targeting Omicron SARS-CoV-2 via pyro-drive jet injector provides the prolonged neutralizing antibody production via germinal center … H Hayashi, J Sun, Y Yanagida, T Otera, JA Tai, T Nishikawa, K Yamashita, ... Scientific Reports 13 (1), 13033, 2023 | 3 | 2023 |
| Peptide-based vaccine targeting IL17A attenuates experimental spondyloarthritis in HLA-B27 transgenic rats H Hayashi, J Sun, Y Yanagida, S Yoshida, S Baba, A Tenma, M Toyoura, ... RMD open 9 (1), e002851, 2023 | 3 | 2023 |
| A vaccine against fibroblast activation protein improves murine cardiac fibrosis by preventing the accumulation of myofibroblasts S Yoshida, H Hayashi, T Kawahara, S Katsuki, M Kimura, R Hino, J Sun, ... Circulation research 136 (1), 26-40, 2025 | 1 | 2025 |
| Impact of insufficient recovery of cerebral blood flow due to partial reperfusion on the pathophysiology of ischemic stroke in mice M Shimamura, C yang Chang, H Hayashi, S Baba, S Yoshida, ... Neuroscience Letters 810, 137370, 2023 | 1 | 2023 |
Nakagami HironoriOsaka University在 gts.med.osaka-u.ac.jp 的电子邮件经过验证
Nakagami HironoriOsaka University在 gts.med.osaka-u.ac.jp 的电子邮件经过验证